Proficio Capital Partners’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-5,325
Closed -$1.24M 132
2019
Q3
$1.24M Hold
5,325
0.46% 47
2019
Q2
$1.25M Sell
5,325
-104
-2% -$24K 0.43% 48
2019
Q1
$1.28M Buy
5,429
+220
+4% +$69.3K 0.46% 46
2018
Q4
$1.57M Sell
5,209
-4
-0.1% -$1.28K 0.7% 32
2018
Q3
$1.84M Buy
5,213
+3
+0.1% +$1.03K 0.61% 30
2018
Q2
$1.51M Buy
5,210
+7
+0.1% +$1.97K 0.62% 35
2018
Q1
$1.43M Sell
5,203
-22
-0.4% -$6.83K 0.42% 41
2017
Q4
$1.67M Buy
5,225
+1,006
+24% +$323K 0.54% 38
2017
Q3
$1.32M Buy
4,219
+1,669
+65% +$494K 0.53% 39
2017
Q2
$734K Sell
2,550
-9
-0.4% -$2.38K 0.3% 68
2017
Q1
$648K Buy
2,559
+89
+4% +$25.2K 0.28% 78
2016
Q4
$700K Buy
2,470
+22
+0.9% +$6.52K 0.3% 76
2016
Q3
$766K Buy
2,448
+20
+0.8% +$5.92K 0.44% 67
2016
Q2
$702K Buy
2,428
+40
+2% +$10.5K 0.44% 66
2016
Q1
$622K Sell
2,388
-6
-0.3% -$1.58K 0.52% 55
2015
Q4
$733K Buy
+2,394
New +$688K 0.72% 43

Other funds holding BIIB

Proficio Capital Partners's BIIB Position: Q4 2019 in Review

Proficio Capital Partners sold out of Biogen (BIIB) in Q4 2019, closing a stake of 5,325 shares — an estimated $1.24M sold.

Proficio Capital Partners first reported a position in BIIB in Q4 2015 and held it in 16 quarters. The position peaked at $1.84M in Q3 2018. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • Proficio Capital Partners reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • Proficio Capital Partners sold 5,325 Biogen shares in Q4 2019, an estimated $1.24M.
  • Proficio Capital Partners first reported a position in Biogen in Q4 2015 and held it in 16 quarters.
  • Proficio Capital Partners's Biogen position peaked at $1.84M in Q3 2018.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on Proficio Capital Partners's 13F filing for Q4 2019, filed 13 Feb 2020.